Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00332085 · ClinicalTrials.gov registry record · Phase 1
Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes
A Phase 1 study, sponsored by Bastyr University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00332085: Clinical Trial Phase 1 study, sponsored by Bastyr University.
NCT00332085 is a Phase 1 study that was terminated before completion, run by Bastyr University. The registered enrollment target is 40 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00332085, a Phase 1 study, was terminated before completion, sponsored by Bastyr University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This pilot trial seeks to gather preliminary data on the combination of chromium picolinate, the most commonly used form of chromium, and metformin. The trial will recruit type 2 diabetes subjects already on metformin and treat them with chromium for 8 weeks. The results of this trial will provide vital preliminary data including safety and size of effect to direct future studies.
Interventions
- DRUG Chromium Picolinate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-01 |
| Est. Completion | 2007-03 |
| Phase | Phase 1 |
Why NCT00332085 stopped before completion
NCT00332085 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% lower).
The record links to 0 conditions, and to 1 intervention - of which Chromium Picolinate is the first listed.
NCT00332085 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00332085 about?
NCT00332085 is a clinical study titled "Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes". This pilot trial seeks to gather preliminary data on the combination of chromium picolinate, the most commonly used form of chromium, and metformin. The trial will recruit type 2 diabetes subjects already on metformin and treat them with chromium for 8 weeks. The results of this trial will provide v...
What is the current status of trial NCT00332085?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2006-01. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00332085?
The interventions under investigation include: Chromium Picolinate (DRUG).
Who is sponsoring clinical trial NCT00332085?
This trial is sponsored by Bastyr University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00332085's enrollment target sits among peer trials
40 1130th of 2000 higher than 810 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia